GENFIT: Upcoming Presentations on NASH, PBC and Diagnostics

GENFIT (Nasdaq and Euronext: GNFT – ISIN: FR0004163111), a late-stage biopharmaceutical company dedicated to the discovery and development of innovative therapeutic and diagnostic solutions in metabolic and liver related diseases, today announced it will present new data at the International Liver Congress (ILC) 2019, which will take place April 10-14 in Vienna, Austria.

Abstracts are available for download and viewing through the International Liver Congress website.

https://www.globenewswire.com/news-release/2019/04/04/1796796/0/en/Genfit-GENFIT-Announces-Upcoming-Presentations-on-NASH-PBC-and-Diagnostics-at-the-European-Association-for-the-Study-of-the-Liver-EASL-International-Liver-Congress-2019.html